iTeos Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ITOS and buy or sell other stocks, ETFs, and their options commission-free!

About ITOS

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. 

CEO
Kevin C. Tang
CEOKevin C. Tang
Employees
173
Employees173
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2012
Founded2012
Employees
173
Employees173

ITOS Key Statistics

Market cap
448.30M
Market cap448.30M
Price-Earnings ratio
-2.09
Price-Earnings ratio-2.09
Dividend yield
—
Dividend yield—
Average volume
1.76M
Average volume1.76M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$17.63
52 Week high$17.63
52 Week low
$4.80
52 Week low$4.80

People also own

Based on the portfolios of people who own ITOS. This list is generated using Robinhood data, and it’s not a recommendation.
Riot Platforms
Plug Power
Snap
Intel
Lucid Group
Pfizer
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.